Sonnet BioTherapeutics Announces Adjournment of Annual Meeting Due to Lack of Quorum
02.06.2022 - PRINCETON, NJ / ACCESSWIRE / June 2, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (Sonnet or the Company), a biopharmaceutical company developing innovative targeted biologic drugs, today announced that the Companys 2022 Annual ... Seite 1
Source: wallstreet-online.de